AlzeCure Pharma

What is your business idea, what problem do you want to solve?
“We are a Swedish drug company focusing on the development of new Alzheimer’s treatments. This challenging and deadly disease, which today affects 30 million people all over the world, has now effective treatment,” says AlzeCure Pharma’s CEO and co-founder Martin Jönsson.

“The team has extensive experience from small and large drug companies, and has also an established network of key opinion formers, including professor Bengt Winblad, one of the most leading researchers in the field.”

Where are you now?
“We’re currently working with two small molecular platforms: NeuroRestore (ACD855), a symptomatic form of therapy directed at nerve cell function disorders, and Alzstatin (ACD678), a disease modifying form of therapy that targets the formation of amyloid plaque in the brain,” says  Jönsson.

“We also have a backup-programme with several powerful substances that can also be interesting for other indications, for example depression.”

What are your plans for the future?
“We’ll continue to develop our priority projects, and we plan to initiate clinical studies of NeuroRestore in 2018 and of Alzstatin in 2019. To be able to implement this ambitious and important programme, in the immediate future we’ll be identifying various suitable financing solutions. Listing the company is one possible option,” says Jönsson.

Why are you in Flemingsberg?
“Our research and development has been conducted in co-operation with Karolinska Institutet and Karolinska University Hospital here in Flemingsberg, and the stimulating environment with access to leading research in the area, and the positive climate on Campus Flemingsberg encourages exciting co-operation,” says Jönsson.



Hälsovägen 7
SE-141 57 Huddinge
+46 703 73 88 24

Published On: 8 September 2022
Lokaler i AWL

A Working Lab

"We saw the potential of Flemingsbergs's rapidly growing campus, with its proximity to the hospital...


"We are in Flemingsberg due to the availability of competent workforce in this sector and...

AlzeCure Pharma

The stimulating environment with access to leading research in the area, and the positive climate...


When we needed more space to establish an integrated facility for all our activities, including...

Biomedrex Genetics

Thanks to great contacts, including Flemingsberg Science, we quickly got a place at Ana Futura...

Cellaviva: improving lives through stem cell technology

Flemingsberg is a cluster for cell therapies that gives us proximity to partners, the clinical...

Inhalation Sciences Sweden

In Flemingsberg, we have access to the advanced labs that we need, and it offers...

Mando Group

Our research and development has been conducted in co-operation with both KI and Karolinska University...

NextCell Pharma

Flemingsberg is entirely the right place for us due to its closeness to co-operation partners...

Go to Top